Literature DB >> 18375524

MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?

J H Chen, O Nalcioglu, M Y Su.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18375524      PMCID： PMC2613432          DOI： 10.1093/annonc/mdn120

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Relationship of estrogen and progesterone receptors to prognosis in breast cancer.

Authors:  G A Gelbfish; A L Davidson; S Kopel; B Schreibman; J S Gelbfish; G A Degenshein; B L Herz; J N Cunningham
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

2.  Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy.

Authors:  Pierre-Jean Lamy; Pascal Pujol; Simon Thezenas; Andrew Kramar; Philippe Rouanet; Françoise Guilleux; Jean Grenier
Journal:  Breast Cancer Res Treat       Date:  2002-11       Impact factor: 4.872

3.  Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Authors:  Grazia Arpino; Heidi Weiss; Adrian V Lee; Rachel Schiff; Sabino De Placido; C Kent Osborne; Richard M Elledge
Journal:  J Natl Cancer Inst       Date:  2005-09-07       Impact factor: 13.506

4.  Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer.

Authors:  R Ponzone; F Montemurro; F Maggiorotto; C Robba; D Gregori; M E Jacomuzzi; F Kubatzki; D Marenco; A Dominguez; N Biglia; P Sismondi
Journal:  Ann Oncol       Date:  2006-09-15       Impact factor: 32.976

5.  Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.

Authors:  Ke-Da Yu; Guang-Yu Liu; Gen-Hong Di; Jiong Wu; Jin-Song Lu; Kun-Wei Shen; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast       Date:  2007-02-12       Impact factor: 4.380

6.  Estrogen receptor and breast MR imaging features: a correlation study.

Authors:  Jeon-Hor Chen; Hyeon-Man Baek; Orhan Nalcioglu; Min-Ying Su
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

7.  Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.

Authors:  Naoki Ikenaga; Naoki Otomo; Atsushi Toyofuku; Yuji Ueda; Kiyokazu Toyoda; Tohru Hayashi; Kiyoshi Nishikawa; Masao Tanaka
Journal:  Am Surg       Date:  2007-11       Impact factor: 0.688

8.  Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.

Authors:  Valerie-Jeanne Bardou; Grazia Arpino; Richard M Elledge; C Kent Osborne; Gary M Clark
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

9.  FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.

Authors:  Andreas Buck; Holger Schirrmeister; Thorsten Kühn; Changxian Shen; Thomas Kalker; Jörg Kotzerke; Anja Dankerl; Gerhard Glatting; Sven Reske; Torsten Mattfeldt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-07-26       Impact factor: 9.236

10.  The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions.

Authors:  Ayse Mavi; Tevfik F Cermik; Muammer Urhan; Halis Puskulcu; Sandip Basu; Jian Q Yu; Hongming Zhuang; Brian Czerniecki; Abass Alavi
Journal:  J Nucl Med       Date:  2007-07-13       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.